Viral and host responses to HSV infection
病毒和宿主对 HSV 感染的反应
基本信息
- 批准号:7318513
- 负责人:
- 金额:$ 33.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:Acute Promyelocytic LeukemiaAddressAffectAfferent NeuronsAntiviral ResponseAreaAxotomyBindingBiochemical GeneticsBlindnessCellsCellular biologyCultured CellsDataDeveloped CountriesDevelopmentDiseaseEpithelial CellsEventFibroblastsGene ExpressionGeneticGenetic ScreeningGenital systemGoalsHealthHeat-Shock ResponseHost DefenseHumanImmediate-Early ProteinsImmune responseInfectionInfectious Disease ImmunologyIntegration Host FactorsInterferon ReceptorInterferonsInterventionLeadLinkLyticLytic PhaseMapsMediatingMolecularMusNuclearOral cavityPathologyPenetrationPhasePhosphoproteinsPhosphorylationPhosphorylation SitePlayPost-Translational Protein ProcessingProcessProteinsPublic HealthPurposeRangeRecurrenceResearchResearch PersonnelRoleSeveritiesSimplexvirusSiteStimulusStressStructureTechniquesTestingTherapeutic InterventionTrans-ActivatorsTransactivationViralViral PhysiologyViral ProteinsVirusVirus DiseasesVirus ReplicationVirus-Cell Membrane InteractionWorkexperienceimprovedin vivoinnovationlatent infectionmouse modelmultidisciplinarymutantnovelpathogenpreventprogramsprotein expressionreactivation from latencyresponsetranscription factor PMLtransmission processubiquitin-protein ligasevirus host interaction
项目摘要
DESCRIPTION (provided by applicant): Herpes simplex virus (HSV) is a common and significant pathogen which causes a variety of disease processes in humans, ranging from cold and genital sores to blindness. The lifecycle of HSV has two distinct phases: lytic and latent infections. A pivotal HSV protein in determining the switch between lytic and latent infections is infected cell protein 0 (ICP0). ICP0 is a 110-KDa nuclear phosphoprotein that strongly transactivates viral gene expression, degrades cellular proteins in nuclear domain (ND) 10, and inhibits the anti-viral response of cellular interferons (IFNs). IFNs are secreted cellular immunomodulatory factors that upregulate the expression of ND10-associated proteins to limit the spread and replication of viruses. Genetics studies have indicated that the ND10-associated protein, promyelocytic leukemia (PML), plays an important role in IFN-mediated inhibition of HSV replication. Thus, it is likely that the interactions between ICP0, PML, and IFNs govern the type of infection HSV will establish. The mechanisms and domains on ICP0 and PML required in virus-host responses to infection through IFNs have been largely undetermined. The long-term objective of our studies is to understand at the molecular level how virus-cell interactions affect HSV infection. The objective of this proposal is to determine how specific motifs on ICP0 and PML modulate the virus-host response. Our central hypothesis is that ICP0 impairs the anti-viral activity of PML, which, in turn, is required for efficient viral replication. To test this hypothesis, we will use a variety of genetic, biochemical, and cell biology techniques to identify motifs on ICP0 and PML that participate in regulating HSV replication. Results from our studies are expected to lead to novel anti-viral therapies that inhibit or limit the severity of HSV diseases. For this purpose, our three Specific Aims are to: 1) Determine the contribution of PML motifs in the IFN response to HSV infection, 2) Identify domains in and sites on ICP0 that serve to counteract host defenses to infection, and 3) Determine the role of ICP0-PML interactions in modulating the cellular anti-viral response. The public health relevance of this research is that HSV infections are the primary cause of infectious blindness in western industrialized countries. From these studies, we expect to identify and characterize crucial connections between HSV (ICP0) and its host (IFN and PML) that determine the type infection HSV will establish. These results may be used to develop novel anti-HSV treatments.
描述(由申请人提供):单纯疱疹病毒(HSV)是一种常见且重要的病原体,可引起人类多种疾病,从感冒和生殖器溃疡到失明。HSV的生命周期有两个不同的阶段:裂解和潜伏感染。决定裂解性和潜伏性感染之间转换的关键HSV蛋白是感染细胞蛋白0(ICP 0)。ICP 0是一种110-KDa的核磷蛋白,其强烈反式激活病毒基因表达,降解核结构域(ND)10中的细胞蛋白,并抑制细胞干扰素(IFN)的抗病毒应答。IFN是分泌的细胞免疫调节因子,其上调ND 10相关蛋白的表达以限制病毒的传播和复制。遗传学研究表明,ND 10相关蛋白,即早幼粒细胞白血病(PML),在IFN介导的HSV复制抑制中起重要作用。因此,ICP 0、PML和IFN之间的相互作用可能决定HSV将建立的感染类型。ICP 0和PML在病毒宿主通过IFN对感染的反应中所需的机制和结构域在很大程度上尚未确定。我们研究的长期目标是在分子水平上了解病毒-细胞相互作用如何影响HSV感染。本提案的目的是确定ICP 0和PML上的特定基序如何调节病毒-宿主反应。我们的中心假设是ICP 0损害PML的抗病毒活性,而PML又是有效病毒复制所必需的。为了验证这一假设,我们将使用各种遗传学、生物化学和细胞生物学技术来鉴定ICP 0和PML上参与调节HSV复制的基序。我们的研究结果有望导致新的抗病毒疗法,抑制或限制HSV疾病的严重程度。为此,我们的三个具体目标是:1)确定PML基序在IFN对HSV感染的应答中的作用,2)鉴定ICP 0上用于抵消宿主对感染的防御的结构域和位点,3)确定ICP 0-PML相互作用在调节细胞抗病毒应答中的作用。这项研究的公共卫生相关性是HSV感染是西方工业化国家传染性失明的主要原因。从这些研究中,我们希望确定和表征HSV(ICP 0)及其宿主(IFN和PML)之间的关键联系,这些联系决定HSV将建立的感染类型。这些结果可用于开发新的抗HSV治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David J Davido其他文献
David J Davido的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David J Davido', 18)}}的其他基金
Identifying functional targets of HSV-1 ICP0-directed degradation
识别 HSV-1 ICP0 定向降解的功能目标
- 批准号:
10043320 - 财政年份:2020
- 资助金额:
$ 33.32万 - 项目类别:
Dissecting the Contribution of Viral Genetic Variation to HSV-1 Neuropathogenesis
剖析病毒遗传变异对 HSV-1 神经发病机制的影响
- 批准号:
9265973 - 财政年份:2016
- 资助金额:
$ 33.32万 - 项目类别:
Improving Vaccine Safety and Efficacy to Control Primary HSV-1 Infections
提高疫苗安全性和有效性以控制原发性 HSV-1 感染
- 批准号:
7945290 - 财政年份:2009
- 资助金额:
$ 33.32万 - 项目类别:
Improving Vaccine Safety and Efficacy to Control Primary HSV-1 Infections
提高疫苗安全性和有效性以控制原发性 HSV-1 感染
- 批准号:
7708388 - 财政年份:2009
- 资助金额:
$ 33.32万 - 项目类别:
INBRE: KU-L: VIRAL AND HOST RESPONSES TO HSV INFECTION
INBRE:KU-L:病毒和宿主对 HSV 感染的反应
- 批准号:
7720194 - 财政年份:2008
- 资助金额:
$ 33.32万 - 项目类别:
INBRE: KU-L: VIRAL AND HOST RESPONSES TO HSV INFECTION
INBRE:KU-L:病毒和宿主对 HSV 感染的反应
- 批准号:
7610221 - 财政年份:2007
- 资助金额:
$ 33.32万 - 项目类别:
IDENTIFYING TARGETS OF E3 UBIQUITIN LIGASES:ROLE IN BRCA1-MEDIATED BREAST CANCER
确定 E3 泛素连接酶的靶标:在 BRCA1 介导的乳腺癌中的作用
- 批准号:
7609721 - 财政年份:2007
- 资助金额:
$ 33.32万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 33.32万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 33.32万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 33.32万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 33.32万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 33.32万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 33.32万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 33.32万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 33.32万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 33.32万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 33.32万 - 项目类别:
Research Grant














{{item.name}}会员




